Post-operative adjuvant therapy for non-small-cell lung cancer

Lung Cancer

Volumn 17, Issue SUPPL. 1, 1997, Pages

  Johnson, D ^c   Arriagada, R ^a   Barthelemy, N ^b   Bonner, J ^c   Bonomi, P ^c   Enami, B ^c   Minatel, E ^c   Park, K ^d   Quoix, E ^e   Van Houtte, P ^f  

^a Instituto de Radiomedicina Santiago   (Chile)

^b CHU SART TILMAN   (Belgium)

^c Cro Aviano and GH Pordenone ^*

^d Samsung Medical Center   (South Korea)

^e UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^f JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; NAVELBINE; PACLITAXEL;

ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; HUMAN; LUNG NON SMALL CELL CANCER; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE CARE; PRIORITY JOURNAL;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; POSTOPERATIVE CARE;

EID: 10644243688     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(97)00040-8     Document Type: Conference Paper

References (1)

1. IASLC Statement on Endpoints for Multimodal Clinical Trials, Lung Cancer 1994;11 Suppl 3:S11-13.